Try our Advanced Search for more refined results
Life Sciences - May, 2025
282 articles
- Pharma Co. Hid Cancer Study Method Problems, Investor Claims
- $5.2M Generic Drug Price-Fixing MDL Deal Gets Final OK
- Wheeling & Appealing: The Latest Must-Know Appellate Action
- Crowdfunding, Reg A Deals Grow Slowly As SEC Weighs Ideas
- TopCo Settles Suit Over Cough Syrup Billed As 'Non-Drowsy'
- Congress Must Restore IP Protection To Drive US Innovation
- ITC Issues Import Block On Ascletis Liver Disease Drugs
- How Focus On Menopause Care Is Fueling Innovation, Access
- The BigLaw Settlements Are About Risk, Not Profit
- Generic-Drug Makers Near Exit From Depo-Provera MDL
- DLA Piper Adds Healthcare Regulatory Atty In DC Office
- Former Pfizer Atty, Motley Rice Adviser Joins DiCello Levitt
- Neb.'s Cannabis Regulatory Void Poses Operational Risks
- AstraZeneca Inks $51.4M Settlement In Pay-For-Delay Case
- CMS Seeks Hospital Responses On Gender Dysphoria Care
- Monsanto-Funded Researcher Influenced Panel, Jury Hears
- Express Scripts Says Arkansas Can't Ban PBM Pharmacies
- Delaware Justices Asked To Review Corporate Law Rework
- Judge Favors Vanda But Seeks Deal Over Drug Approval
- Ex-USPTO Solicitor Says He's Against Squires Nomination
- Drugstores Say Texas Flouted Rules To Update Pharmacy Regs
- Ex-United Therapeutics Exec Can't Dodge IP Suit
- Cochlear Implant Rivals Call Truce Ahead Of UPC Ruling
- Courts Must Revitalize Robust Claim Construction
- What Gene Findings Mean For Asbestos Mesothelioma Claims
- Brazilian Jiujitsu Makes Me A Better Lawyer
- 16 States Sue Trump Admin Over Cuts To Science Grants
- 5 Federal Circuit Clashes To Watch In June
- Regeneron Urges Judge In FCA Kickback Suit To Set Trial Date
- Fla. Judge Told Pharma Co. Rival Also Stole Trade Secrets
- Fed. Circ. Lets Stewart Revise Longhorn Sanctions Order
- 3rd Circ. Pauses J&J Unit Appeal In Talc Study Libel Case
- Drugmaker LIVation Fights Novo Nordisk's Trademark Claims
- Class Suit Against AI Drugmaker Back On After Mediation Fails
- Indian Pharma Co. Hit With Patent Suit Over Fennec's Cancer Drug
- Mallinckrodt Investors Get Initial OK For $5.5M Settlement
- Singapore's Quadria Closes $1B-Plus Healthcare Fund
- Mich. School, Student GOP Club Spar In Free Speech Suit
- Vt. Judge To Order Release Of Harvard Researcher
- Fed. Circ. In April: Introducing New Evidence During IPR
- Checkpoint Pharma Sued For Docs On $355M Merger Plan
- FDA Commissioner Speech Suggests New Vision For Agency
- China Can't Duck PPE Hoarding Claims By Fla. Medical Pros
- Freshfields Gains New Tech M&A Leadership From Debevoise
- Kirkland Hires 3 M&A Partners From Skadden
- Cooley Adds Ex-FDA Attorney To DC Life Sciences Group
- Bluebird Bio Beats Investor Suit Over FDA Cancer Warning
- Philips Can't Nix Suit Over Sleep Machine Catching Fire
- Bayer, Monsanto On Hook For $611M Roundup Cancer Awards
- Bankrupt 23andMe To Delist Stock After Regeneron Deal
- DOJ Export Declination Highlights Self-Reporting Benefits
- Feds No Longer Advise COVID Shot For Kids, Pregnant Adults
- AG Watch: Texas Expands Use Of Consumer Protection Laws
- Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker
- Justices Deny Food Wrapping Co.'s Prior Art Petition
- Law360 Reveals Titans Of The Plaintiffs Bar
- Fed. Circ. Lifts Stay Against MSN In Entresto Appeal
- Meta, App Maker Flo Can't Escape All Of Privacy Class Action
- LegitScript Can't Use 'Unclean Hands' To Ax Antitrust Case
- Seattle Cancer Center Inks $11.5M Class Data Breach Deal
- Fed. Circ. Dings PTAB Decision Upholding X-Ray Patent
- Ex-McKinsey Exec Sentenced For Obstructing Purdue Probe
- Power To The Paralegals: An Untapped Source For Biz Roles
- Trump Admin Must Restore 'Censored' Harvard Docs' Articles
- FTC Probing Alcon's $430M Lensar Deal
- Biotech Insider Traded On $3.5B Novartis Deal, Feds Say
- A Path Forward For Colo. Pot Products After Failed Safety Test
- Class Of Health Plans Certified In Avandia Marketing MDL
- My So-Called Retirement: Some IP Lawyers Just Can't Quit
- Cooley Hires 'Next-Gen' Boston Labor & Employment Partner
- Ballard Spahr Adds IP Transactions Pro From DLA Piper
- Insulet Foe Rips $30M Atty Fee Ask As 'Over-Lawyered'
- Fed. Circ. Backs Pfizer Win Against Gene Therapy Patents
- Senators Unveil DNA Privacy Bill Amid 23andMe's Ch. 11 Sale
- Calif. Docs Bring FDA Stem Cell Regulation Fight To Top Court
- Justices Urged To Undo Denial Of Fast Track For Gastro Drug
- EpiPen Direct Buyers, Mylan Get Final OK On Antitrust Deal
- Manufacturer Seeks Over $19M In Beryllium Release Coverage
- Judge Asks If DEI Is Now 'Homogeneity, Inequity And Exclusion'
- Playing Poker Makes Me A Better Lawyer
- Conn. AG Targets 'Bootleg' Weight Loss Drug Sellers
- What EU 'Killer Acquisition' Study Means For Pharma Deals
- Sanofi To Acquire Goodwin-Led US Biotech Biz For $470M
- FTC Urges 8th Circ. Not To Pause In-House PBM Case
- Squires Talks Fortress, PTAB Invalidations In Senate Hearing
- 9th Circ. Judge Asks If Apple's Watch Updates 'Ice Out' Rivals
- Judge Mulls National Scope Of Bid To Restore COVID Grants
- AbbVie Gets Victory In Allergan Shareholder Suit Upheld
- GOP FTC Renews Calls For Orange Book Patent Delistings
- Legal Risks For Providers Discussing Psychedelic Therapies
- Kronos Bio Shareholder Says Sale Unfairly Benefits Execs
- Device Maker Who Evaded Tax Gets 2 Years In Prison
- Walgreens Ducks False Ad Suit Over Mucus Relief Meds
- Law School's Missed Lessons: Becoming A Firmwide MVP
- Flo Users Get Class Cert. In Google, Meta Data-Sharing Suit
- Barclays Officials Beat Shareholder's Suit At NY High Court
- Novo Fights To Keep Info Bid In $800M Fraud Dispute Alive
- Cancer Drug Co. Beats Investor Suit Over FDA Rejection
- Medical Organizations Sue Feds For Removing Health Data
- Medical Supply Co. Faces Ga. Suit Over Unwanted Texts
- Moderna Says Order To Narrow Vax IP Case Should Stay
- Creditors Win Fight Against Insider Releases In Azzur Ch. 11
- Biotech Stockholders Challenge Director Pay Levels In Del.
- Sales Exec Admits Role In $70M Brain Scan Kickback Scheme
- Trade Secrets Would Likely See Court Protection From GenAI
- A Breakdown Of Trump's Order On Drug Pricing
- Former Kite Pharma Exec Alleges Gender Bias, Retaliation
- SEC's 'Shadow Trading' Win Should Be Tossed, 9th Circ. Told
- Ex-CTA Worker Can Take Vaccine Bias Claim To Trial
- Feds Get Early Win In Drugmakers' Suit Over 340B Rebates
- Bluebird Beats Patent Case Over Blood Disease Therapies
- Biotech Services Company Files Ch. 11 With $60M In Debt
- Cosmetic Co. Considerations As More States Target PFAS
- Wachtell-Led Regeneron To Buy 23andMe, Gaining User Data
- Covington Corporate M&A Atty Moves To Clifford Chance
- USPTO Seeks Input On Guidelines For Fighting Online Fakes
- IPO Pipeline Restarts As Tariff-Related Volatility Eases
- J&J Unit Hit With $147M Verdict In Catheter Antitrust Suit
- Biotech Co. Hit With Investor Suits Over Cancer Drug Launch
- Parents Sue Colgate Over Alleged Dangers Of Fluoride Rinse
- Bank Balks At Nostrum Ch. 11 Sale Over Drug Disposal Issue
- Illumina Accuses Ex-Workers' Co. Of Infringing Gene Tech IP
- Feds Want Ex-McKinsey Exec To Serve Time For Obstruction
- Del. Bill Reflects Nat'l Tug-Of-War Between Cannabis, Alcohol
- Ex-Womble Bond Atty Heads To Chicago With Shook Hardy
- 23 States Win Order Halting Billions In HHS Public Health Cuts
- Cooley, Goodwin Build BioMarin's $270M Inozyme Buy
- Trump Admin Settles Vaccine Contract Info Suit For $10K
- $38M Law Firm Settlement Highlights 'Unworthy Client' Perils
- J&J Unit's Economist Rips Rival's $147M Antitrust Damage Bid
- 7th Circ. Weighs AbbVie Whistleblower's Drug Marketing Suit
- Novo's Real Target In Doc Bid Is $800M Arbitration, Co. Says
- UMich Protesters Say Lives 'Upended' By Campus Bans
- Maintaining Legal Compliance For GenAI In Life Sciences
- Trending At The PTAB: The Influence Of Litigation Arguments
- Bausch, Mylan Settle Patent Suit Over Generic IBS Drugs
- Harvard Researcher Held By ICE To Be Returned To Mass.
- Amarin Tells Justices Hikma Has Gotten Far Ahead Of Itself
- Teaching Business Law Makes Me A Better Lawyer
- Curaleaf And Ex-VP In Settlement Talks, Court Told
- Davis Wright Adds Longtime Knobbe Martens IP Duo In Seattle
- Regeneron Wins $271.2M In Amgen Antitrust Suit
- Actinium Faces Derivative Suit Over FDA Application Claims
- J&J Unit's Catheter Policy Stopped Free-Riding, Jury Told
- RJ Reynolds Can Keep Trial Win In Engle Case, Court Says
- Integra Brass Face Investor Suit Over FDA Compliance Lapses
- Regeneron-Amgen Trial Goes To Jury With An Extra Day
- Sage Therapeutics Brass Sued Over Drug Candidate Claims
- 2nd Circ. Has Tough Questions On Nixing Medical Imaging Award
- 10th Circ. Chilly To Biotech's SEC Asset Freeze Challenge
- Harvard Researcher Charged With Smuggling Amid ICE Case
- Alnylam Halts Patent Row Over Pfizer, BioNTech COVID-19 Vax
- Novo Nordisk, Septerna Ink Up To $2.2B Obesity Drug Deal
- D'Oh! Kimberly-Clark Can't Keep Wage Suit In Federal Court
- Deregulation Memo Presents Risks, Opportunities For Cos.
- Eckert Seamans Enters NYC With 11 Hawkins Parnell Attys
- Biotech Firm Verax Tells Court Eviction Could End Company
- RFK Jr. Defends HHS Cuts, Pledges To 'Spend Smarter'
- Law School's Missed Lessons: Mastering Discovery
- Biogen Sues Ex-Collaborator Over Rights To Drug Tech
- Asterisk Doesn't Save CVS In Sanitizer Row, 9th Circ. Told
- PTAB Ramps Up Fintiv Denials After Withdrawal Of Memo
- Magistrate Judge Cuts Defendants In J&J Talc Unit Fraud Suit
- Becton Dickinson Sues Baxter Over Infusion Pump Patents
- Regeneron-Amgen Drug Bundling Trial Heads Toward Jury
- 10x Genomics, Bruker Strike Deal After $31M Patent Verdict
- NIH Letters Ending Grants Lack Factual Support, Judge Says
- PBMs Get Bipartisan Bashing At Hearing On Drug Costs
- Cancer Centers Want Fed. Circ. To Rehear Antibody IP Fight
- Former J&J, Moderna Exec Joins Goodwin Procter In Boston
- Maneuvering The Weeds Of Cannabis Vertical Integration
- Express Scripts, FTC Say Defamation Suit 'Should Proceed'
- W.Va. High Court Declines 4th Circ. Request For Opioid Input
- Missouri Hit With Sanctions In Generics Price-Fixing Fight
- Fed. Circ. Erases MIT, Broad CRISPR Win In Conception Fight
- Mass. Court Says NIH Grant Disruption Suit Is In The Right Place
- UTC Again Seeks To Stave Off Lung Drug Competitor In IP Suit
- AGs Call Sandoz Deal's Consumer-Side Benefits 'Illusory'
- Fla. Pharmacy Beats Novo Nordisk Suit Over Ozempic 'Copies'
- 20 AGs Suing HHS Move to Halt Cuts At 4 Affected Agencies
- The IRS Shouldn't Go To War Over Harvard's Tax Exemption
- Fed. Circ. Won't Revive Sydnexis Eye Drop Patents
- Will Justices Finally Rein In Universal Injunctions?
- J&J Co.'s Catheter Policy Limited Choices, Doc Testifies
- Pathology Lab Urges 8th Circ. Not To Revive Antitrust Claims
- Private Fundraising Takes Hit Amid Volatile Backdrop
- More Conn. Dentists Reach Kickback Deals With AG, Feds
- Souter's Clerks Remember Him As Humble, Kind And Caring
- Insulet Seeks $30M In Atty Fees, Costs After Trade Secret Win
- Hiker And 'Raconteur': Atty Recalls 50-Year Bond With Souter
- A Look At David Souter's Most Significant Opinions
- Justice Souter Was An Unexpected Force Of Moderation
- UK-US Trade Deal Needs Work On Pharma And IP, Pros Say
- Playing Guitar Makes Me A Better Lawyer
- Retired Supreme Court Justice David Souter Dies At 85
- J&J Unit's Encryption Tech Stalled Rival, Antitrust Jury Told
- AMAG Inks $7.5M Deal In Suit Over Preterm-Birth Drug
- Ruling Over Expired Bard Patent Causes Split, Justices Told
- Colo. Court Sets Next Toxic Tort Bellwether For January
- Counterfeit Goods Hit $467B Globally In 2021, Report Says
- Court Upholds CMA's £99M Thyroid Drug Price Fines
- Bayer Says Wash. Law, FDA Preempt IUD Defect Allegations
- Albertsons Says Counties Have 'Paradoxical Status' In MDL
- Fed. Circ. Weighs If Expert's Testimony Justifies Spine IP Loss
- Hikma Cuts $50M Deal To End Antitrust Claims In Xyrem MDL
- 3rd Circ. Rejects Challenge To Medicare Drug Price Program
- Judge Asks DOJ To Define DEI In Health Grant Case
- Biotech Tells Chancery Drug Co. Abused Merger Prospects
- Crisis Management Lessons From The Parenting Playbook
- Elizabeth Holmes Loses Bid For Full 9th Circ. Rehearing
- Justices' Labcorp Questions Explore Class Cert. Tensions
- Ala. Legislature OKs TCJA Research Expense Decoupling
- Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan
- J&J Unit's Catheter Tying Policy Hurt Rival, Antitrust Jury Told
- FDA Gets Win In Eli Lilly Weight Loss Drug Shortage Fight
- Investors Fight J&J, Kenvue Bid To Nix IPO Fraud Suit
- Fertility Co. Accused Of Selling Bogus Tests Wasting Embryos
- Patent Examiners Tell GAO Quantity Beats Quality
- Fed. Circ. Clears Way For Sun Pharma Alopecia Drug
- Rite Aid Cleared For Quick Ch. 11 Sale Plans
- $525M Nuke Services Deal Faces Canada Competition Probe
- Insulet Pursues EOFlow's Finances After $60M Ruling
- Shionogi To Acquire Torii Pharma Through $1.1B Tender Offer
- Walgreens Wants 'Far-Fetched' Shareholder Suit Tossed
- 4 Legislative Proposals Reflect Growing Scrutiny Of Pharma IP
- Device Seller Asks For Probation In $2.4M Tax Evasion Case
- Orrick Hires Boston Duo For Life Sciences Practice
- Masimo Unloads Embattled Audio Unit In $350M Sale
- Adapting To Private Practice: From NY Fed To BigLaw
- Post-Ch. 11 Rite Aid Trustee Asks To Take Over Insurance Suit
- Medical Device Co. SeaStar Seeks Toss Of Shareholder Suit
- Quarles & Brady Adds New IP, Real Estate Partners
- Fed. Circ. Asks What Law Applies For Sleep Drug Injunction
- Haemonetics Sues Terumo Over Plasma Tech Patents
- Mylan Agrees To Keep Nausea Generics Off Market Until 2032
- Mistrial Declared On Punitive Damages In Bard Cancer Case
- Ex-CEO Can't Shake Conviction In COVID Test Kit Fraud Case
- 7 Considerations For Conducting Drug Clinical Trials Abroad
- Trade Secrets Emerge As Path For Cos. To Protect AI Works
- Top 3 Litigation Finance Deal-Killers, And How To Avoid Them
- Trump Orders FDA To Speed Up Drug Plant Approvals
- Gene-Editing Co. Synthego Hits Ch. 11 With Sights On A Sale
- DC Circ. Has Doubts About Narcolepsy Drug Appeal
- Liquidia Fends Off Indication Challenge In UTC Tyvaso Fight
- 8th Circ. Backs Boehringer's Copyright Win Over Software Co.
- Regeneron, Amgen Open Drug 'Bundling' Trial In Del.
- PTAB Says It's Bedtime For Sleep Apnea Patent Claims
- Trump Admin Urges Dismissal Of States' Abortion Pill Suit
- Pharma Co. Escapes Investor Liver Drug Trial Suit, For Now
- Rite Aid Hits Bankruptcy Less Than A Year After Previous Ch. 11
- 5th Circ. Ruling Is Latest Signal Of Shaky Qui Tam Landscape
- Purdue Tells Justices 'Rigid' Fed. Circ. Rule Threatens Patents
- Exactech Committee Calls Foul On Ch. 11 Voting Packages
- How Attys Can Use A Therapy Model To Help Triggered Clients
- Novartis, Incyte Settle Drug Royalty Fight On Eve Of Trial
- High Court Won't Hear Challenge To Miss. Ban On Pot Ads
- Insulin Giants' Antitrust Victory On Shaky Ground At 2nd Circ.
- Boston Scientific, FDA Sued Over 'Unsafe' Spinal Implant
- Plaintiffs Seek Redo Over Sterilization Co.'s Trial Tactics
- Tax Case Can Proceed Despite Late Name Change, Court Says
- Fed. Circ. Gives MSN Short Pause For Entresto Appeal
- Ex-SCWorx CEO Seeks Sentencing Delay Over Restitution Row
- CR Bard Owes $20M In Ga. Ethylene Oxide Cancer Trial
- Faegre Drinker Lands Patent Team From Wilson Sonsini
- Goodwin Adds Scientist IP Partner From Cooley On West Coast
- 23andMe Says 1.3M Customers Have Asked To Delete Data
- Taxation With Representation: Goodwin, Haynes Boone
- 3 Steps For In-House Counsel To Assess Litigation Claims
- HHS Report Finds 'Serious Concerns' On Trans Care For Youth
- 5 Fed. Circ. Clashes To Watch This Month
- CR Bard Owes For Plant Neighbor's Illness, Jury Told
- Couple's J&J Pelvic Mesh Claims Too Late, 11th Circ. Affirms
- Publix Can't Slip 'Zero-Market Share' Opioid Claims
- PBMs Tell 6th Circ. Ohio's Pricing Case Belongs In Fed Court
- Senators Reintroduce Patent Eligibility, PTAB Reform Bills
- US Tells Justices Telemedicine Case Isn't Ideal For Eligibility
- J&J Talc Unit Says New Doc 'Key' To Talc Study Libel Suit
- Payment Math Dooms Sandoz Price-Fixing Deal With Florida
- J&J's Failed 3rd Try Casts Doubt On Use Of 'Texas Two-Step'
- Paul Hastings, GenapSys Settle Calif. Legal Malpractice Suit
- McCarter & English Fights Ex-Client's $1M Fee Reduction Bid
- Teaching College Students Makes Me A Better Lawyer